Point72 Asset Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-236,855
| Closed | -$379K | – | 1374 |
|
|
2025
Q1 | $379K | Buy |
236,855
+40,389
| +21% | +$64.6K | ﹤0.01% | 1025 |
|
|
2024
Q4 | $707K | Sell |
196,466
-1,005,382
| -84% | -$3.62M | ﹤0.01% | 937 |
|
|
2024
Q3 | $6.85M | Buy |
1,201,848
+923,268
| +331% | +$5.26M | 0.02% | 572 |
|
|
2024
Q2 | $1.29M | Sell |
278,580
-627,892
| -69% | -$2.9M | ﹤0.01% | 783 |
|
|
2024
Q1 | $7.41M | Sell |
906,472
-1,054,887
| -54% | -$8.62M | 0.02% | 665 |
|
|
2023
Q4 | $11.1M | Buy |
1,961,359
+1,945,338
| +12,142% | +$11M | 0.03% | 547 |
|
|
2023
Q3 | $29.8K | Buy |
16,021
+9,464
| +144% | +$17.6K | ﹤0.01% | 1547 |
|
|
2023
Q2 | $18K | Sell |
6,557
-17,176
| -72% | -$47.2K | ﹤0.01% | 1273 |
|
|
2023
Q1 | $74.5K | Buy |
+23,733
| New | +$74.5K | ﹤0.01% | 1193 |
|
|
2022
Q2 | – | Sell |
-503,888
| Closed | -$12.2M | – | 1071 |
|
|
2022
Q1 | $12.2M | Buy |
+503,888
| New | +$12.2M | 0.05% | 419 |
|
|
2021
Q4 | – | Sell |
-200,000
| Closed | -$8.94M | – | 1043 |
|
|
2021
Q3 | $8.94M | Buy |
200,000
+34,400
| +21% | +$1.54M | 0.04% | 487 |
|
|
2021
Q2 | $6.27M | Buy |
+165,600
| New | +$6.27M | 0.03% | 524 |
|